Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Characteristics of adherence to methadone maintenance treatment over a 15-year period among homeless adults experiencing mental illness.

Parpouchi M, Moniruzzaman A, Rezansoff SN, Russolillo A, Somers JM.

Addict Behav Rep. 2017 Sep 23;6:106-111. doi: 10.1016/j.abrep.2017.09.001. eCollection 2017 Dec.

2.

Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders.

Russolillo A, Moniruzzaman A, McCandless LC, Patterson M, Somers JM.

Addiction. 2017 Oct 7. doi: 10.1111/add.14059. [Epub ahead of print]

PMID:
28987068
3.

Food Insecurity among Homeless Adults with Mental Illness.

Parpouchi M, Moniruzzaman A, Russolillo A, Somers JM.

PLoS One. 2016 Jul 20;11(7):e0159334. doi: 10.1371/journal.pone.0159334. eCollection 2016.

4.

Accuracy of reported service use in a cohort of people who are chronically homeless and seriously mentally ill.

Somers JM, Moniruzzaman A, Currie L, Rezansoff SN, Russolillo A, Parpouchi M.

BMC Psychiatry. 2016 Feb 25;16:41. doi: 10.1186/s12888-016-0758-0.

5.

A 10-year retrospective analysis of hospital admissions and length of stay among a cohort of homeless adults in Vancouver, Canada.

Russolillo A, Moniruzzaman A, Parpouchi M, Currie LB, Somers JM.

BMC Health Serv Res. 2016 Feb 17;16:60. doi: 10.1186/s12913-016-1316-7.

6.

The prevalence and geographic distribution of complex co-occurring disorders: a population study.

Somers JM, Moniruzzaman A, Rezansoff SN, Brink J, Russolillo A.

Epidemiol Psychiatr Sci. 2016 Jun;25(3):267-77. doi: 10.1017/S2045796015000347. Epub 2015 May 20.

PMID:
25989819
7.

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R; CaRRDs Study Group.

Ann Rheum Dis. 2014 Jun;73(6):1157-62. doi: 10.1136/annrheumdis-2012-202812. Epub 2013 Jun 14.

8.

Improving the use of direct oral anticoagulants in atrial fibrillation.

Di Minno G, Russolillo A, Gambacorta C, Di Minno A, Prisco D.

Eur J Intern Med. 2013 Jun;24(4):288-94. doi: 10.1016/j.ejim.2013.01.021. Epub 2013 Apr 8. Review.

PMID:
23579170
9.

Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.

Di Minno MN, Russolillo A, Di Minno A, Camera M, Parolari A, Tremoli E.

Expert Opin Emerg Drugs. 2013 Mar;18(1):9-23. doi: 10.1517/14728214.2013.777427. Review.

PMID:
23448155
10.

[New oral anticoagulants: recommendations, precautions and perspectives for use].

Di Minno G, Russolillo A, Ventre I, Di Minno A, Prisco D.

G Ital Cardiol (Rome). 2012 Nov;13(11 Suppl 1):28S-37S. doi: 10.1714/1179.13064. Italian.

PMID:
23160017
11.

Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study.

Di Minno MN, Dentali F, Veglia F, Russolillo A, Tremoli E, Ageno W.

Thromb Haemost. 2013 Jan;109(1):167-9. doi: 10.1160/TH12-09-0663. Epub 2012 Nov 29. No abstract available.

PMID:
23196409
12.

Stroke prevention: from available antiplatelet drugs to novel molecular targets.

Di Minno MN, Momi S, Di Minno A, Russolillo A.

Curr Drug Targets. 2013 Jan 1;14(1):3-12. Review.

PMID:
23170792
13.

Ropivacaine infusion in diabetics subject with peripheral arterial disease. A prospective study.

Di Minno MN, Milone M, Russolillo A, Lupoli R, Di Minno A, Maietta P, Iacovazzo C, Salvatore G, Milone F.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):91-3. doi: 10.1055/s-0032-1327757. Epub 2012 Nov 12.

PMID:
23147211
14.

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.

Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G.

World J Gastroenterol. 2012 Nov 7;18(41):5839-47. doi: 10.3748/wjg.v18.i41.5839. Review.

15.

Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study.

Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Tarantino G, Scarpa R.

Arthritis Res Ther. 2012 Oct 4;14(5):R211. doi: 10.1186/ar4049.

16.

Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management.

Russolillo A, Iervolino S, Peluso R, Lupoli R, Di Minno A, Pappone N, Di Minno MN.

Rheumatology (Oxford). 2013 Jan;52(1):62-7. doi: 10.1093/rheumatology/kes242. Epub 2012 Sep 18. Review.

PMID:
22989426
17.

Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis.

di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, di Minno G.

Arthritis Care Res (Hoboken). 2013 Jan;65(1):141-7. doi: 10.1002/acr.21711.

18.

Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers.

Di Minno MN, Iervolino S, Peluso R, Russolillo A, Lupoli R, Scarpa R, Di Minno G, Tarantino G; CaRRDS Study Group.

J Rheumatol. 2012 May;39(5):1042-6. doi: 10.3899/jrheum.111391. Epub 2012 Mar 15.

PMID:
22422493
19.

Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.

Di Minno MN, Iervolino S, Lupoli R, Russolillo A, Coppola A, Peluso R, Scarpa R, Di Minno G.

Semin Thromb Hemost. 2012 Jul;38(5):497-505. doi: 10.1055/s-0032-1306433. Epub 2012 Mar 7. Review.

PMID:
22399309
20.

Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers.

Iervolino S, Di Minno MN, Peluso R, Lofrano M, Russolillo A, Di Minno G, Scarpa R.

J Rheumatol. 2012 Mar;39(3):568-73. doi: 10.3899/jrheum.110763. Epub 2012 Jan 15.

PMID:
22247361
21.

Alcohol dosing and the heart: updating clinical evidence.

Di Minno MN, Franchini M, Russolillo A, Lupoli R, Iervolino S, Di Minno G.

Semin Thromb Hemost. 2011 Nov;37(8):875-84. doi: 10.1055/s-0031-1297366. Epub 2011 Dec 23. Review.

PMID:
22198852
22.

Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.

Di Minno MN, Lupoli R, Palmieri NM, Russolillo A, Buonauro A, Di Minno G.

Thromb Res. 2012 Mar;129(3):341-4. doi: 10.1016/j.thromres.2011.11.020. Epub 2011 Dec 3. Review.

PMID:
22142668
23.

Filling the gap between science & clinical practice: prevention of stroke recurrence.

Russolillo A, Di Minno MN, Tufano A, Prisco D, Di Minno G.

Thromb Res. 2012 Jan;129(1):3-8. doi: 10.1016/j.thromres.2011.08.012. Epub 2011 Sep 9. Review.

PMID:
21907395
24.

Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis.

Di Minno MN, Iervolino S, Peluso R, del Puente A, Russolillo A, Coppola A, Ruosi C, Guida A, Scarpa R, Di Minno G.

Clin Rheumatol. 2011 Jul;30(7):915-9. doi: 10.1007/s10067-011-1707-4. Epub 2011 Feb 16.

PMID:
21327686
25.

New anti-thrombotic drugs for stroke prevention.

Di Minno MN, Russolillo A, Camera M, Brambilla M, De Gregorio A, Tremoli E, Di Minno G.

Curr Vasc Pharmacol. 2011 Nov;9(6):723-32. Review.

PMID:
21143164
26.

Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective.

Di Minno MN, Tremoli E, Tufano A, Russolillo A, Lupoli R, Di Minno G.

Thromb Haemost. 2010 Oct;104(4):664-80. doi: 10.1160/TH10-01-0008. Epub 2010 Aug 30. Review.

PMID:
20806105
27.

Sarcopenia: age-related skeletal muscle changes from determinants to physical disability.

Di Iorio A, Abate M, Di Renzo D, Russolillo A, Battaglini C, Ripari P, Saggini R, Paganelli R, Abate G.

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):703-19. Review.

PMID:
17166393

Supplemental Content

Loading ...
Support Center